{"DataElement":{"publicId":"6333698","version":"1","preferredName":"Pharmacologic Substance Product Material Code ACT I2B2 CDM Dose Form Code","preferredDefinition":"An active natural, synthetic or semi-synthetic ingredient including endogenous body substance that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient (21 CFR 314.3(b)).:The end result of a manufacturing process; anything that is produced.:The tangible substance that goes into the makeup of a physical object._A system of numbered categories for representation of data._Medication concept in coding system.","longName":"3760536v1.0:6265619v1.0","context":"CDMH","contextVersion":"1","DataElementConcept":{"publicId":"3760536","version":"1","preferredName":"Pharmacologic Substance Product Material Code","preferredDefinition":"An active natural, synthetic or semi-synthetic ingredient including endogenous body substance that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient (21 CFR 314.3(b)).:The end result of a manufacturing process; anything that is produced.:The tangible substance that goes into the makeup of a physical object._A system of numbered categories for representation of data.","longName":"2867693v1.0:2222855v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2867693","version":"1","preferredName":"Pharmacologic Substance Product Material","preferredDefinition":"An active natural, synthetic or semi-synthetic ingredient including endogenous body substance that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient (21 CFR 314.3(b)).:The end result of a manufacturing process; anything that is produced.:The tangible substance that goes into the makeup of a physical object.","longName":"C1909:C51980:C48187","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pharmacologic Substance","conceptCode":"C1909","definition":"Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Product","conceptCode":"C51980","definition":"The end result of a manufacturing process; anything that is produced.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Material","conceptCode":"C48187","definition":"The tangible substance that goes into the makeup of a physical object.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6941772E-ECAA-1039-E040-BB89AD437C46","latestVersionIndicator":"Yes","beginDate":"2009-05-06","endDate":null,"createdBy":"UMLLOADER_BRIDGPRD","dateCreated":"2009-05-06","modifiedBy":"ONEDATA","dateModified":"2009-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2222855","version":"1","preferredName":"Code","preferredDefinition":"A system of numbered categories for representation of data.","longName":"C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F621162F-5C48-4F85-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER_EVS","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DCA7E52E-7F9D-EFF5-E040-BB89AD431688","latestVersionIndicator":"Yes","beginDate":"2013-05-13","endDate":null,"createdBy":"UMLLOADER_BRIDGPRD","dateCreated":"2013-05-14","modifiedBy":"DWARZEL","dateModified":"2022-05-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6265619","version":"1","preferredName":"ACT I2B2 CDM Dose Form Code","preferredDefinition":"Medication concept in coding system.","longName":"6265619v1.0","context":"CDMH","contextVersion":"1","type":"Non-enumerated","dataType":"Integer","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2435024","version":"1","preferredName":"Drug or Chemical","preferredDefinition":"A category of organic or inorganic substances, elements, and isotopes used in research or for the prevention, diagnosis, and/or treatment of disease states. Includes biologically active substances that are either synthetically manufactured or endogenous substances extracted and processed to be reintroduced into an organism. Chemicals and drugs also include hazardous substances, and naturally occurring or synthetically produced substances required to maintain life.","longName":"C1908","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB04-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2261841","version":"1","preferredName":"Code","preferredDefinition":"A system of numbered categories for representation of data.","longName":"C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FBB87F7A-6427-1AFC-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-07-13","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ACT CDM:The Accrual to Clinical Trials Network Common Data Model","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B573FAB-8F29-4B65-E053-F662850A1D78","latestVersionIndicator":"Yes","beginDate":"2018-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-03","modifiedBy":"COOPERM","dateModified":"2019-02-20","changeDescription":"Based on RxNorm Form for ACT I2B2 CDM.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6093471","version":"1.4","longName":"i2b2 ACT Network CDM 1.4","context":"CDMH","ClassificationSchemeItems":[{"publicId":"6093474","version":"1.4","longName":"Medication","context":"CDMH"}]}],"AlternateNames":[{"name":"MEDICATION_CODE","type":"ACT Name","context":"CDMH"},{"name":"MEDICATION","type":"ACT Table","context":"CDMH"}],"ReferenceDocuments":[{"name":"Medication Code","type":"Preferred Question Text","description":"Medication Code","url":null,"context":"CDMH"}],"origin":"ACT CDM:The Accrual to Clinical Trials Network Common Data Model","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E23E5FE-6FD2-6A5D-E053-F662850AA28D","latestVersionIndicator":"Yes","beginDate":"2018-06-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-08","modifiedBy":"ONEDATA","dateModified":"2023-03-10","changeDescription":"Based on CDMH BRIDG 5.0.2 and ACT I2B2 value set for CDM. Remove alternate name containing the table name. DW 11-07-2019","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}